Vanda Comes Up Empty Handed As US Supreme Court Denies Hetlioz Appeal
ANDA Sponsors Teva, Apotex, Already Launched At Risk Following Earlier Win
Vanda looks likely to have to face up to unimpeded US generic competition to its core Hetlioz brand, after a further denial in its litigation against ANDA sponsors Teva and Apotex.
